Supersensitive presynaptic dopamine D2 receptor inhibition of the striatopallidal projection in nigrostriatal dopamine-deficient mice

Journal of Neurophysiology

Volumn 110, Issue 9, 2013, Pages 2203-2216

  Wei, Wei ^a,b   Li, Li ^a   Yu, Guoliang ^a   Ding, Shengyuan ^a   Li, Chengyao ^b   Zhou, Fu Ming ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Basal ganglia; Dopamine receptor; Globus pallidus; Parkinson's disease; Presynaptic inhibition

Indexed keywords

DOPAMINE 2 RECEPTOR; PRESYNAPTIC RECEPTOR; TRANSCRIPTION FACTOR PITX3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; CONTROLLED STUDY; DOPAMINE DEFICIENT MOUSE; GLOBUS PALLIDUS; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE ENDING; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPTIC TRANSMISSION;

BASAL GANGLIA; DOPAMINE RECEPTOR; GLOBUS PALLIDUS; PARKINSON'S DISEASE; PRESYNAPTIC INHIBITION;

ACTION POTENTIALS; ANIMALS; DOPAMINE; DOPAMINERGIC NEURONS; GABAERGIC NEURONS; GLOBUS PALLIDUS; HOMEODOMAIN PROTEINS; INHIBITORY POSTSYNAPTIC POTENTIALS; MICE; MICE, MUTANT STRAINS; MUTATION; PRESYNAPTIC TERMINALS; RECEPTORS, DOPAMINE D2; SUBSTANTIA NIGRA; TRANSCRIPTION FACTORS;

EID: 84887011313     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00161.2013     Document Type: Article

References (118)

1. Bateup HS, Santini E, Shen W, Birnbaum S, Valjent E, Surmeier DJ, Fisone G, Nestler EJ, Greengard P. Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc Natl Acad Sci USA 107: 14845-14850, 2010.
2. Benhamou L, Bronfeld M, Bar-Gad I, Cohen D. Globus pallidus external segment neuron classification in freely moving rats: a comparison to primates. PLoS One 7: e45421, 2012.
3. Betarbet R, Greenamyre JT. Regulation of dopamine receptor and neuro-peptide expression in the basal ganglia of monkeys treated with MPTP. Exp Neurol 189: 393-403, 2004.
4. Beurrier C, Ben-Ari Y, Hammond C. Preservation of the direct and indirect pathways in an in vitro preparation of the mouse basal ganglia. Neuroscience 140: 77-86, 2006.
5. Bezard E, Porras G, Blesa J, Obeso J. Compensatory mechanisms in experimental and human parkinsonism: potential for new therapies. In: Handbook of Basal Ganglia Structure and Function, edited by Steiner H, Tseng KY. London: Academic, 2010.
6. Björklund A, Lindvall O. Dopamine-containing systems in the CNS. In: Classical Transmitters in the CNS, Part I, edited by Björklund A, Hokfelt T. Amsterdam: Elsevier, 1984.
7. Bolam JP, Hanley JJ, Booth PA, Bevan MD. Synaptic organisation of the basal ganglia. J Anat 196: 527-542, 2000.
8. Cai G, Wang HY, Friedman E. Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum. J Pharmacol Exp Ther 302: 1105-1112, 2002.
9. Chan CS, Glajch KE, Gertler TS, Guzman JN, Mercer JN, Lewis AS, Goldberg AB, Tkatch T, Shigemoto R, Fleming SM, Chetkovich DM, Osten P, Kita H, Surmeier DJ. HCN channelopathy in external globus pallidus neurons in models of Parkinson's disease. Nat Neurosci 14: 85-92, 2011.
10. Chuhma N, Tanaka KF, Hen R, Rayport S. Functional connectome of the striatal medium spiny neuron. J Neurosci 31: 1183-1192, 2011.
11. Cooper AJ, Stanford IM. Electrophysiological and morphological characteristics of three subtypes of rat globus pallidus neurone in vitro. J Physiol 527: 291-304, 2000.
12. Cooper AJ, Stanford IM. Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABAA IPSCs in vitro. Neuropharmacology 41: 62-71, 2001.
13. Creese I, Burt DR, Snyder SH. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science 197: 596-598, 1977.
14. Day M, Wang Z, Ding J, An X, Ingham CA, Shering AF, Wokosin D, Ilijic E, Sun Z, Sampson AR, Mugnaini E, Deutch AY, Sesack SR, Arbuth-nott GW, Surmeier DJ. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 9: 251-259, 2006.
15. Deister CA, Dodla R, Barraza D, Kita H, Wilson CJ. Firing rate and pattern heterogeneity in the globus pallidus arise from a single neuronal population. J Neurophysiol 109: 497-506, 2013.
16. Delgado A, Sierra A, Querejeta E, Valdiosera RF, Aceves J. Inhibitory control of the GABAergic transmission in the rat neostriatum by D2 dopamine receptors. Neuroscience 95: 1043-1048, 2000.
17. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13: 281-285, 1990.
18. Ding J, Guzman JN, Tkatch T, Chen S, Goldberg JA, Ebert PJ, Levitt P, Wilson CJ, Hamm HE, Surmeier DJ. RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat Neurosci 9: 832-842, 2006.
19. Ding S, Li L, Zhou FM. Presynaptic serotonergic gating of the subthalam-onigral glutamatergic projection. J Neurosci 33: 4875-4885, 2013.
20. Ding Y, Restrepo J, Won L, Hwang DY, Kim KS, Kang UJ. Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease. Neurobiol Dis 27: 11-23, 2007.
21. Ding Y, Won L, Britt JP, Lim SA, McGehee DS, Kang UJ. Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice. Proc Natl Acad Sci USA 108: 840-845, 2011.
22. Durieux PF, Bearzatto B, Guiducci S, Buch T, Waisman A, Zoli M, Schiffmann SN, de Kerchove d'Exaerde A. D2R striatopallidal neurons inhibit both locomotor and drug reward processes. Nat Neurosci 12: 393-395, 2009.
23. Elias S, Joshua M, Goldberg JA, Heimer G, Arkadir D, Morris G, Bergman H. Statistical properties of pauses of the high-frequency discharge neurons in the external segment of the globus pallidus. J Neurosci 27: 2525-2538, 2007.
24. Fioravante D, Regehr WG. Short-term forms of presynaptic plasticity. Curr Opin Neurobiol 21: 269-274, 2011.
25. Fujiyama F, Sohn J, Nakano T, Furuta T, Nakamura KC, Matsuda W, Kaneko T. Exclusive and common targets of neostriatofugal projections of rat striosome neurons: a single neuron-tracing study using a viral vector. Eur J Neurosci 33: 668-677, 2011.
26. Geldwert D, Norris JM, Feldman IG, Schulman JJ, Joyce MP, Rayport S. Dopamine presynaptically and heterogeneously modulates nucleus accum-bens medium-spiny neuron GABA synapses in vitro. BMC Neurosci 7: 53, 2006.
27. Gerfen CR, Bolam JP. The neuroanatomical organization of the basal ganglia. In: Handbook of Basal Ganglia Structure and Function, edited by Steiner H, Tseng KY. London: Academic, 2010.
28. Gerfen CR, Surmeier DJ. Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 34: 441-466, 2011.
29. 35S]GTPgammaS binding in striatum of 6-hydroxydopamine-lesioned rats. Brain Res 841: 135-142, 1999.
30. Graham WC, Clarke CE, Boyce S, Sambrook MA, Crossman AR, Woodruff GN. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis). Brain Res 514: 103-110, 1990b.
31. Graham WC, Crossman AR, Woodruff GN. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat. Brain Res 514: 93-102, 1990a.
32. Guerra MJ, Liste I, Rozas G, Tobio J, Labandeira-Garcia JL. Previous dopaminergic innervation is not necessary for the development of dopamine supersensitivity in rat striatal neurons. Neurosci Lett 206: 137-140, 1996.
33. Günay C, Edgerton JR, Jaeger D. Channel density distributions explain spiking variability in the globus pallidus: a combined physiology and computer simulation database approach. J Neurosci 28: 7476-7491, 2008.
34. Guzmán JN, Hernández A, Galarraga E, Tapia D, Laville A, Vergara R, Aceves J, Bargas J. Dopaminergic modulation of axon collaterals interconnecting spiny neurons of the rat striatum. J Neurosci 23: 8931-8940, 2003.
35. Hedreen JC. Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus. J Comp Neurol 409: 400-410, 1999.
36. Hedreen JC, DeLong MR. Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque. J Comp Neurol 304: 569-95, 1991.
37. Hernandez LF, Kubota Y, Hu D, Howe MW, Lemaire N, Graybiel AM. Selective effects of dopamine depletion and l-DOPA therapy on learning-related firing dynamics of striatal neurons. J Neurosci 33: 4782-4795, 2013.
38. 2+ currents and excitability via a novel PLCbeta1-IP3-calcineurin-signaling cascade. J Neurosci 20: 8987-8995, 2000.
39. 2+ influx by D2 dopamine and A2A adenosine receptors. Nat Neurosci 13: 958-966, 2010.
40. Hornykiewicz O. Chemical neuroanatomy of the basal ganglia-normal and in Parkinson's disease. J Chem Neuroanat 22: 3-12, 2001.
41. Hwang DY, Ardayfio P, Kang UJ, Semina EV, Kim KS. Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Brain Res Mol Brain Res 114: 123-131, 2003.
42. Hwang DY, Fleming SM, Ardayfio P, Moran-Gates T, Kim H, Tarazi FI, Chesselet MF, Kim KS. 3,4-Dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. J Neurosci 25: 2132-2137, 2005.
43. Jan C, François C, Tandé D, Yelnik J, Tremblay L, Agid Y, Hirsch E. Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients. Eur J Neurosci 12: 4525-4535, 2000.
44. Jung AB, Bennett JP Jr. Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) andD2 (D2a) receptors. Brain Res Dev Brain Res 94: 109-120, 1996.
45. Kim DS, Froelick GJ, Palmiter RD. Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum. J Neurosci 22: 9841-9849, 2002.
46. Kim J, Kita H. Short-term plasticity shapes activity pattern-dependent striatopallidal synaptic transmission. J Neurophysiol 109: 932-939, 2013.
47. Kim DS, Szczypka MS, Palmiter RD. Dopamine-deficient mice are hypersensitive to dopamine receptor agonists. J Neurosci 20: 4405-4413, 2000.
48. Kita H. Organization of the globus pallidus. In: Handbook of Basal Ganglia Structure and Function, edited by Steiner H, Tseng KY. London: Academic, 2010.
49. Kita H, Kita T. Cortical stimulation evokes abnormal responses in the dopamine-depleted rat basal ganglia. J Neurosci 31: 10311-10322, 2011a.
50. Kita H, Kita T. Role of striatum in the pause and burst generation in the globus pallidus of 6-OHDA-treated rats. Front Syst Neurosci 5: 42, 2011b.
51. Kohnomi S, Koshikawa N, Kobayashi M. D2-like dopamine receptors differentially regulate unitary IPSCs depending on presynaptic GABAergic neuron subtypes in rat nucleus accumbens shell. J Neurophysiol 107: 692-703, 2012.
52. Kostrzewa RM. Dopamine receptor supersensitivity. Neurosci Biobehav Rev 19: 1-17, 1995.
53. Kravitz AV, Freeze BS, Parker PR, Kay K, Thwin MT, Deisseroth K, Kreitzer AC. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466: 622-626, 2010.
54. Kreitzer AC, Malenka RC. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 445: 643-647, 2007.
55. Lévesque M, Parent A. The striatofugal fiber system in primates: a reevalu-ation of its organization based on single-axon tracing studies. Proc Natl Acad Sci USA 102: 11888-11893, 2005.
56. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90: 8861-8865, 1993.
57. Li L, Qiu G, Ding S, Zhou FM. Serotonin hyperinnervation and upregulated 5-HT2A receptor expression and motor-stimulating function in nigrostriatal dopamine-deficient Pitx3 mutant mice. Brain Res 1491: 236-250, 2013.
58. Li L, Zhou FM. Parallel dopamine D1 receptor activity dependence of L-Dopa-induced normal movement and dyskinesia in mice. Neuroscience 236: 66-76, 2013.
59. Mallet N, Micklem BR, Henny P, Brown MT, Williams C, Bolam JP, Nakamura KC, Magill PJ. Dichotomous organization of the external globus pallidus. Neuron 74: 1075-1086, 2012.
60. Mandel RJ, Hartgraves SL, Severson JA, Woodward JJ, Wilcox RE, Randall PK. A quantitative estimate of the role of striatal D-2 receptor proliferation in dopaminergic behavioral supersensitivity: the contribution of mesolimbic dopamine to the magnitude of 6-OHDA lesion-induced agonist sensitivity in the rat. Behav Brain Res 59: 53-64, 1993.
61. Mansour A, Meador-Woodruff JH, Bunzow JR, Civelli O, Akil H, Watson SJ. Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J Neurosci 10: 2587-2600, 1990.
62. Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R, Kaneko T. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci 29: 444-453, 2009.
63. Michaeli A, Yaka R. Dopamine inhibits GABAA currents in ventral tegmental area dopamine neurons via activation of presynaptic G-protein coupled inwardly-rectifying potassium channels. Neuroscience 165: 1159-1169, 2010.
64. Miguelez C, Morin S, Martinez A, Goillandeau M, Bezard E, Bioulac B, Baufreton J. Altered pallido-pallidal synaptic transmission leads to aberrant firing of globus pallidus neurons in a rat model of Parkinson's disease. J Physiol 590: 5861-5875, 2012.
65. Miller BR, Walker AG, Shah AS, Barton SJ, Rebec GV. Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease. J Neurophysiol 100: 2205-2216, 2008.
66. Mizuno T, Schmauss C, Rayport S. Distinct roles of presynaptic dopamine receptors in the differential modulation of the intrinsic synapses of medium-spiny neurons in the nucleus accumbens. BMC Neurosci 8: 8, 2007.
67. Nambu A. Somatotopic organization of the primate basal ganglia. Front Neuroanat 5: 26, 2011.
68. Nambu A, Chiken S, Shashidharan P, Nishibayashi H, Ogura M, Kak-ishita K, Tanaka S, Tachibana Y, Kita H, Itakura T. Reduced pallidal output causes dystonia. Front Syst Neurosci 5: 89, 2011.
69. Newman-Tancredi A, Cussac D, Brocco M, Rivet JM, Chaput C, Touzard M, Pasteau V, Millan MJ. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra. Brain Res 920: 41-54, 2001.
70. Nunes I, Tovmasian LT, Silva RM, Burke RE, Goff SP. Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc Natl Acad Sci USA 100: 4245-4250, 2003.
71. Obeso JA, Marin C, Rodriguez-Oroz C, Blesa J, Benitez-Temiño B, Mena-Segovia J, Rodríguez M, Olanow CW. The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Ann Neurol 64, Suppl 2: S30-S46, 2008.
72. 2+ channels is dependent on a Shank-binding domain. J Neurosci 25: 1050-1062, 2005.
73. Parent M, Wallman MJ, Gagnon D, Parent A. Serotonin innervation of basal ganglia in monkeys and humans. J Chem Neuroanat 41: 256-265, 2011.
74. Pons R, Syrengelas D, Youroukos S, Orfanou I, Dinopoulos A, Cormand B, Ormazabal A, Garzía-Cazorla A, Serrano M, Artuch R. Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency. Mov Disord 28: 1058-1063, 2013.
75. Prensa L, Parent A. The nigrostriatal pathway in the rat: a single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments. J Neurosci 21: 7247-7260, 2001.
76. 2+ current modulation in neostriatal neurons. Neuroscience 164: 345-350, 2009.
77. Qin ZH, Chen JF, Weiss B. Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors. J Neurochem 62: 411-420, 1994.
78. Rajput AH, Sitte HH, Rajput A, Fenton ME, Pifl C, Hornykiewicz O. Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology 70: 1403-1410, 2008.
79. Rakhilin SV, Olson PA, Nishi A, Starkova NN, Fienberg AA, Nairn AC, Surmeier DJ, Greengard P. A network of control mediated by regulator of calcium/calmodulin-dependent signaling. Science 306: 698-701, 2004.
80. Rao PA, Molinoff PB, Joyce JN. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Brain Res Dev Brain Res 60: 161-177, 1991.
81. Raz A, Vaadia E, Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 20: 8559-8571, 2000.
82. Rice ME. Use of ascorbate in the preparation and maintenance of brain slices. Methods 18: 144-149, 1999.
83. 2+ channel current and its dopaminergic D2 modulation in developing neostriatal neurons. J Neurophysiol 94: 3771-3787, 2005.
84. Sani S, Ostrem JL, Shimamoto S, Levesque N, Starr PA. Single unit "pauser" characteristics of the globus pallidus pars externa distinguish primary dystonia from secondary dystonia and Parkinson's disease. Exp Neurol 216: 295-299, 2009.
85. Sano H, Chiken S, Hikida T, Kobayashi K, Nambu A. Signals through the striatopallidal indirect pathway stop movements by phasic excitation in the substantia nigra. J Neurosci 33: 7583-7594, 2013.
86. Sano H, Yasoshima Y, Matsushita N, Kaneko T, Kohno K, Pastan I, Kobayashi K. Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function. J Neurosci 23: 9078-9088, 2003.
87. Schambra UB, Duncan GE, Breese GR, Fornaretto MG, Caron MG, Fremeau RT Jr. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience 62: 65-85, 1994.
88. Schwarting RK, Huston JP. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 50: 275-331, 1996.
89. High receptors. Synapse 61: 1013-1018, 2007.
90. High states, implying many paths to psychosis. Proc Natl Acad Sci USA 102: 3513-3518, 2005a.
91. high receptors. Synapse 58: 122-128, 2005b.
92. Selemon LD, Goldman-Rakic PS. Topographic intermingling of striatonigral and striatopallidal neurons in the rhesus monkey. J Comp Neurol 297: 359-376, 1990.
93. Shen KZ, Zhu ZT, Munhall A, Johnson SW. Dopamine receptor supersen-sitivity in rat subthalamus after 6-hydroxydopamine lesions. Eur J Neurosci 18: 2967-2974, 2003.
94. Shin RM, Masuda M, Miura M, Sano H, Shirasawa T, Song WJ, Ko-bayashi K, Aosaki T. Dopamine D4 receptor-induced postsynaptic inhibition of GABAergic currents in mouse globus pallidus neurons. J Neurosci 23: 11662-11672, 2003.
95. Sims RE, Woodhall GL, Wilson CL, Stanford IM. Functional characterization of GABAergic pallidopallidal and striatopallidal synapses in the rat globus pallidus in vitro. Eur J Neurosci 28: 2401-2408, 2008.
96. Smidt MP, Smits SM, Bouwmeester H, Hamers FP, van der Linden AJ, Hellemons AJ, Graw J, Burbach JP. Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development 131: 1145-1155, 2004.
97. Smith Y, Kieval JZ. Anatomy of the dopamine system in the basal ganglia. Trends Neurosci 23: S28-S33, 2000.
98. Smith Y, Villalba R. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Mov Disord 23, Suppl 3: S534-S547, 2008.
99. Soares J, Kliem MA, Betarbet R, Greenamyre JT, Yamamoto B, Wich-mann T. Role of external pallidal segment in primate parkinsonism: comparison of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism and lesions of the external pallidal segment. J Neu-rosci 24: 6417-6426, 2004.
100. Starr PA, Rau GM, Davis V, Marks WJ Jr, Ostrem JL, Simmons D, Lindsey N, Turner RS. Spontaneous pallidal neuronal activity in human dystonia: comparison with Parkinson's disease and normal macaque. J Neurophysiol 93: 3165-3176, 2005.
101. Staunton DA, Magistretti PJ, Koob GF, Shoemaker WJ, Bloom FE. Dopaminergic supersensitivity induced by denervation and chronic receptor blockade is additive. Nature 299: 72-74, 1982.
102. Taverna S, Ilijic E, Surmeier DJ. Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease. J Neurosci 28: 5504-5512, 2008.
103. Tecuapetla F, Carrillo-Reid L, Bargas J, Galarraga E. Dopaminergic modulation of short-term synaptic plasticity at striatal inhibitory synapses. Proc Natl Acad Sci USA 104: 10258-10263, 2007.
104. Tecuapetla F, Koós T, Tepper JM, Kabbani N, Yeckel MF. Differential dopaminergic modulation of neostriatal synaptic connections of striatopal-lidal axon collaterals. J Neurosci 29: 8977-8990, 2009.
105. Thomson AM. Molecular frequency filters at central synapses. Prog Neuro-biol 62: 159-196, 2000.
106. Thomson AM. Presynaptic frequency- and pattern-dependent filtering. J Comput Neurosci 15: 159-202, 2003.
107. 14C-2-deoxyglucose auto-radiography. J Neurosci 12: 2875-2879, 1992.
108. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367: 69-93, 1971.
109. van den Munckhof P, Gilbert F, Chamberland M, Lévesque D, Drouin J. Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of Parkinson's disease. J Neurochem 96: 160-170, 2006.
110. van den Munckhof P, Luk KC, Ste-Marie L, Montgomery J, Blanchet PJ, Sadikot AF, Drouin J. Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development 130: 2535- 2542, 2003.
111. Voorn P. Projections from pallidum to striatum. In: Handbook of Basal Ganglia Structure and Function, edited by Steiner H, Tseng KY. London: Academic, 2010.
112. Watanabe K, Kita T, Kita H. Presynaptic actions of D2-like receptors in the rat cortico-striato-globus pallidus disynaptic connection in vitro. J Neuro-physiol 101: 665-671, 2009.
113. West AR, Grace AA. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. J Neurosci 22: 294-304, 2002.
114. Wichmann T, Dostrovsky JO. Pathological basal ganglia activity in movement disorders. Neuroscience 198: 232-244, 2011.
115. 2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors. J Neurochem 98: 481-494, 2006.
116. Yung KK, Bolam JP, Smith AD, Hersch SM, Ciliax BJ, Levey AI. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65: 709-730, 1995.
117. Zhou FW, Jin Y, Matta SG, Xu M, Zhou FM. An ultra-short dopamine pathway regulates basal ganglia output. J Neurosci 29: 10424-10435, 2009.
118. Zucker RS, Regehr WG. Short-term synaptic plasticity. Annu Rev Physiol 64: 355-405, 2002.